Regulation of erythropoietin production

European Journal of Clinical Investigation, Supplement

Volumn 35, Issue 3, 2005, Pages 13-19

  Eckardt, Kai Uwe ^a   Kurtz, A ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anaemia; Erythropoiesis; Gene regulation; Hypoxia; Oxygen

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; TRANSCRIPTION FACTOR;

ANEMIA; ANIMAL CELL; BETA CHAIN; BLOOD VESSEL TONE; ENHANCER REGION; ERYTHROPOIESIS; FEEDBACK SYSTEM; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENETIC REGULATION; HEMATOCRIT; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; OXYGEN TENSION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; REVIEW; TISSUE OXYGENATION; TRANSCRIPTION REGULATION;

EID: 28944455407     PISSN: 0960135X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01525.x     Document Type: Review

References (69)

1. Miescher F. Ueber die Beziehungen zwischen Meereshöhe und Beschaffenheit des Blutes. Korrespbl Schweiz Arz 1893;23:809-30.
2. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990;248:378-81.
3. Rossert J, Casadevall N, Eckardt KU. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol 2004;15:398-406.
4. Yoshimura A, Misawa H. Physiology and function of the erythropoietin receptor. Curr Opin Hematol 1998;5:171-6.
5. Chen C, Sytkowski AJ. The erythropoietin receptor and its signalling cascade. In: Jelkmann W, editor, Erythropoietin: molecular biology and clinical use. Johnson City, TN: Graham Publishing Co;2003.pp.165-94.
6. Caro J, Brown S, Miller O, Murray T, Erslev AJ. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979;93:449-58.
7. Halvorsen S, Roh BL, Fisher JW. Erythropoietin production in nephrectomized and hypophysectomized animals. Am J Physiol 1968;215:349-52.
8. Ma Y, Freitag P, Zhou J, Brune B, Frede S, Fandrey J. Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia-inducible factor-1. Am J Physiol Regul Integr Comp Physiol 2004;287:R600-7.
9. Bondurant MC, Koury MJ. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 1986;6:2731-3.
10. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 1992;263:F474-81.
11. Eckardt KU, Ratcliffe PJ, Tan CC, Bauer C, Kurtz A. Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J Clin Invest 1992;89:753-60.
12. Tan CC, Eckardt KU, Ratcliffe PJ. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int 1991;40:69-76.
13. Naets JP, Garcia JF, Tousaaint C, Buset M, Waks D. Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients. Scand J Haematol 1986;37:390-4.
14. Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993;41:335-41.
15. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993;44:1149-62.
16. Koury ST, Bondurant MC, Koury MJ, Semenza GL. Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood 1991;77:2497-503.
17. Maxwell PH, Ferguson DJ, Osmond MK, Pugh CW, Heryet A, Doe BG et al. Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells. Blood 1994;84:1823-30.
18. Goldberg MA, Gaut CC, Bunn HF. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 1991;77:271-7.
19. Eckardt KU, Ring A, Maier M, Gess B, Fabbro D, Kurtz A. Hypoxia-induced accumulation of erythropoietin mRNA in isolated hepatocytes is inhibited by protein kinase C. Pflugers Arch 1994;426:21-30.
20. Ratcliffe PJ, Jones RW, Phillips RE, Nicholls LG, Bell JI. Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNase protection. J Exp Med 1990;172:657-60.
21. Scholz H, Schurek HJ, Eckardt KU, Kurtz A, Bauer C. Oxygen-dependent erythropoietin production by the isolated perfused rat kidney. Pflugers Arch 1991;418:228-33.
22. Rejman AS, Grimes AJ, Cotes PM, Mansell MA, Joekes AM. Correction of anaemia following renal transplantation: serial changes in serum immunoreactive erythropoietin, absolute reticulocyte count and red-cell creatine levels. Br J Haematol 1985;61:421-31.
23. Besarab A, Caro J, Jarrell BE, Francos G, Erslev AJ. Dynamics of erythropoiesis following renal transplantation. Kidney Int 1987;32:526-36.
24. Eckardt KU, LeHir M, Tan CC, Ratcliffe PJ, Kaissling B, Kurtz A. Renal innervation plays no role in oxygen-dependent control of erythropoietin mRNA levels. Am J Physiol 1992;263:F925-30.
25. Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989;74:645-51.
26. Eckardt KU, Koury ST, Tan CC, Schuster SJ, Kaissling B, Ratcliffe PJ et al. Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int 1993;43:815-23.
27. 2. Pflugers Arch 1969;309:328-49.
28. Schurek HJ, Jost U, Baumgartl H, Bertram H, Heckmann U. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol 1990;259:F910-5.
29. Erslev AJ, Caro J, Besarab A. Why the kidney? Nephron 1985;41:213-6.
30. Pagel H, Jelkmann W, Weiss C. A comparison of the effects of renal artery constriction and anemia on the production of erythropoietin. Pflugers Arch 1988;413:62-6.
31. Eckardt KU, Kurtz A, Bauer C. Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol 1989;256:F942-7.
32. Law ML, Cai GY, Lin FK, Wei Q, Huang SZ, Hartz JH et al. Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism. Proc Natl Acad Sci USA 1986;83:6920-4.
33. Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985;313:806-10.
34. Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985;82:7580-4.
35. Recny MA, Scoble HA, Kim Y. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. J Biol Chem 1987;262:17156-63.
36. Blanchard KL, Acquaviva AM, Galson DL, Bunn HF. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 1992;12:5373-85.
37. Pugh CW, Tan CC, Jones RW, Ratcliffe PJ. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene. Proc Natl Acad Sci USA 1991;88:10553-7.
38. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12:5447-54.
39. 2- regulated gene expression. FASEB J 2002;16:1151-62.
40. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-5.
41. Metzen E, Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing. Biol Chem 2004;385:223-30.
42. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998;92:2260-8.
43. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002;13:1721-32.
44. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003;17:271-3.
45. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M et al. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 2004;18:1462-4.
46. Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, Antonarakis SE. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci USA 1991;88:8725-9.
47. Maxwell PH, Ferguson DJ, Nicholls LG, Johnson MH, Ratcliffe PJ. The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 1997;52:715-24.
48. Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr 1988;113:1015-21.
49. Tan CC, Tan LH, Eckardt KU. Erythropoietin production in rats with post-ischemic acute renal failure. Kidney Int 1996;50:1958-64.
50. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79:1987-94.
51. Priyadarshi A, Periyasamy S, Burke TJ, Britton SL, Malhotra D, Shapiro JI. Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat. Kidney Int 2002;61:542-6.
52. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001;24:495-9.
53. Eckardt KU, Mollmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G et al. Erythropoietin in polycystic kidneys. J Clin Invest 1989;84:1160-6.
54. Kazal LA, Erslev AJ. Erythropoietin production in renal tumors. Ann Clin Lab Sci 1975;5:98-109.
55. Hammond D, Winnick S. Paraneoplastic erythrocytosis and ectopic erythropoietins. Ann NY Acad Sci 1974;230:219-27.
56. Sufrin G, Mirand EA, Moore RH, Chu TM, Murphy GP. Hormones in renal cancer. J Urol 1977;117:433-8.
57. Da Silva JL, Lacombe C, Bruneval P, Casadevall N, Leporrier M, Camilleri JP et al. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood 1990;75:577-82.
58. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865-75.
59. Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 2001;61:5215-22.
60. Wiesener MS, Seyfarth M, Warnecke C, Jurgensen JS, Rosenberger C, Morgan NV et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood 2002;99:3562-5.
61. Berridge MV, Fraser JK, Carter JM, Lin FK. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 1988;72:970-7.
62. Ishibashi T, Koziol JA, Burstein SA. Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro. J Clin Invest 1987;79:286-9.
63. Erbayraktar S, Yilmaz O, Gokmen N, Brines M. Erythropoietin is a multifunctional tissue-protective cytokine. Curr Hematol Rev 2003;2:465-70.
64. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 2004;10:93-8.
65. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004;207:3233-42.
66. Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003;17:1754-5.
67. Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003;112:999-1007.
68. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003;108:79-85.
69. Binley K, Askham Z, Iqball S, Spearman H, Martin L, de Alwis M et al. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 2002;100:2406-13.